Anti-Omalizumab (Human) ELISA Kit
Size: 96 Well
Application: Anti-drug antibody / immunogenicity testing.
A sandwich ELISA kit for the qualitative detection of Anti-Omalizumab in Human serum and plasma.
Omalizumab (Xolair®) is a recombinant DNA-derived humanized IgG1k monoclonal antibody that selectively binds to human immunoglobulin E (IgE). Xolair inhibits the binding of IgE to the high-affinity IgE receptor (FceRI) on the surface of mast cells and basophils. Reduction in surface-bound IgE on FceRI-bearing cells limits the degree of release of mediators of the allergic response. Xolair is used to treat severe, persistent asthma. However, some patients develop unwanted immunogenicity, which leads to production of anti-drug-antibodies (ADAs) inactivating the therapeutic effects of the treatment and, in rare cases, inducing adverse effects. 96Trace’s BioSimTM anti-Omalizumab ELISA kit is designed to detect antibody against Omalizumab with high specificity and sensitivity in biological matrices.
| Assay Format | Sandwich ELISA |
| Species Reactivity | Human |
| Sample Type | Human serum and plasma |
| Detection Method | Absorbance (450 nm) |
| Detection Wavelength | 450 nm |
| Kit Size | 96 Well |
This ELISA kit is used for qualitative detection of Anti-Omalizumab in Human serum and plasma.
| Storage | +4°C |
| Shipping | Gel Pack |
| Shelf Life | 12 Months |
| Catalog Number | TRC-00103 |
| Analyte / Target | Anti-Omalizumab |